Goals · Specialty & Clinical
Clinical GH deficiency in children and adults. Medical indication, under physician supervision.
Compounds linked to this goal in the catalogue, ordered by role — primary, then support, then optional. Roles follow peptide-db's per-use effectiveness rating (most effective → primary, effective → support, moderate or thinner → optional); a compound that reaches the goal through a curated stack or a condition page says so. Click any card for the full mechanism, dosing, and evidence.
Short-Acting Growth Hormone Releasing Hormone Analog
Half-life: 30 minutes - 2 hours
Long-Acting Growth Hormone Releasing Hormone Analog | Extended Release
Half-life: 6-8 days
Human Growth Hormone | Somatropin
Half-life: 3-4 hours (SC), 20-30 minutes (IV)
Growth Hormone Secretagogue | Selective GHRP
Half-life: ~2 hours
Ghrelin Receptor Agonist | Oral Growth Hormone Secretagogue
Half-life: ~24 hours
GHRH Analog | Visceral Fat Reduction
Half-life: 26-38 minutes
NNMT Inhibitor | Longevity & Metabolic Enhancement
Half-life: 4-7 hours (3.8h IV, 6.9h oral)
Optional — Curated stack: Visceral Fat (Tesamorelin)
Human Chorionic Gonadotropin | LH Receptor Agonist
Half-life: 24-36 hours
Optional — Cryptorchidism · moderate
No SARMs tagged for this goal yet.
No compounds tagged for this goal yet.